Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Haihua Bio-technology is a biotechnology company specializing in the research, development, and production of veterinary biological products. Located in the China Medical City in Taizhou, Jiangsu, the company focuses on high-end vaccines for the livestock industry, particularly for swine health. Their core technological strengths include reverse genetics, high-density cell culture, and advanced purification processes. The company's product portfolio features vaccines for Classical Swine Fever, Porcine Reproductive and Respiratory Syndrome (PRRS), and Porcine Circovirus. Jiangsu Haihua Bio-technology aims to provide comprehensive solutions for animal disease prevention and control through innovation in vaccine technology. The company is recognized as a National High-tech Enterprise and maintains GMP-certified manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Hai Hua Bio-technology.